It has become a tradition within BEAMER to gather during the autumn months for a technical progress assessment and to strategize upcoming efforts. This year was no exception. The Consortium convened in the charming city of Thessaloniki, Greece, for a two-day event from October 19 to 20, 2023, hosted by the Centre for Research and Technology Hellas, a key partner leading several technical BEAMER solutions.
Originally, the meeting in Thessaloniki was primarily intended to delve into the architecture and components of BEAMER solutions, discussing their current status, updates, and future directions. However, as discussions around the agenda matured, it became evident that the collaborative efforts during the meeting would also help define the BEAMER ecosystem and its solutions, expanding the horizons of its impact on the healthcare industry. Most importantly, it explored potential outcomes for patients through a deeper understanding of adherence.
Over the course of the two-day agenda, the Consortium worked diligently to assess the status of BEAMER Models, discussing the detailed architecture of the BEAMER ecosystem, technical implementation foundations, and all the tasks on the roadmap from the current point to the alignment of future action items. A particular focus was given to the data that would be utilized, newly generated, and mapped to existing standards, such as OMOP (Observational Medical Outcomes Partnership). It’s worth mentioning that the BEAMER team consistently evaluates industry trends and initiatives supporting data, tools, and knowledge interoperability, which the Thessaloniki meeting strongly showcased.
One of the most significant successes arising from the meeting’s preparation and live collaboration was the development of a clear plan with key milestones on the path to BEAMER Proof-of-Concept (PoC) – v1 and beyond. The team finalized a set of user workflows and core expected functionalities derived from user needs, with a focus on usability and other aspects of the interfaces, following a user-centred design approach.
This meeting, which welcomed numerous technical partners, provided an invaluable opportunity for the team to better understand each other’s approaches and talents, which is vital given the ambitious project plan and the need for extensive joint efforts. The discussions and joint exercises fostered agreements among partners, ensuring clarity in roles, responsibilities, and technical operations within BEAMER.
As the partners left the technical meeting, they did so with renewed enthusiasm, eagerly anticipating the upcoming opportunities in the BEAMER journey. These opportunities will lead to the Adherence Intelligence Visualization Platform delivering BEAMER Models to analyze patient adherence and the establishment of an Adherence Data Lab, which will support research, development, and future innovation in the field of adherence.
Feel free to share your thoughts by contacting us
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)
It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.
These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.
Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.
The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.
The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.
“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”